Table 2 Physician practice with respect to buprenorphine induction
From: Buprenorphine unobserved “home” induction: a survey of Ontario’s addiction physicians
| N (%) | |
|---|---|
| Practice | |
| Patients attends clinic in withdrawal and all of first day’s doses observed at clinic (N = 81) | |
| Rarely or never | 8 (10) |
| Sometimes | 13 (16) |
| Usually | 13 (16) |
| Almost always | 47 (58) |
| Patients attend clinic in withdrawal, 1–2 doses observed, take-home doses for rest of the day (N = 80) | |
| Rarely or never | 27 (34) |
| Sometimes | 28 (35) |
| Usually | 12 (15) |
| Almost always | 13 (16) |
| Patients given take-home doses for 1–2 days, instructed to take first dose after onset of withdrawal (N = 80) | |
| Rarely or never | 63 (79) |
| Sometimes | 10 (12) |
| Usually | 3 (4) |
| Experience: I end up prescribing methadone because: | |
| The patient doesn’t want to be in withdrawal (N = 81) | |
| Rarely or never | 17 (21) |
| Sometimes | 38 (47) |
| Usually | 20 (25) |
| Almost always | 6 (7) |
| The patient misses the induction appointment or has trouble arriving in withdrawal on induction day (N = 80) | |
| Rarely or never | 39 (49) |
| Sometimes | 32 (40) |
| Usually | 8 (10) |
| Almost always | 1 (1) |
| Almost always | 4 (5) |